Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
GSM8791696 |
PBMCs from mouse M1 collected at endpoint
|
SRA | 1 | Rachel Danielle Saxe | Feb 12, 2025 | ||||
GSM8791695 |
FLARE founder tag and clone tag sequencing associated with sample1_scRNA_c1498_pool
|
SRA | 1 |
|
Rachel Danielle Saxe | Feb 12, 2025 | |||
GSM8791694 |
MULTIseq barcodes for demultiplexing sample1_scRNA_c1498_pool
|
SRA | 1 | Rachel Danielle Saxe | Feb 12, 2025 | ||||
GSM8791693 |
C1498 founder pool, multiplexed control, resistant, and persistent flasks
|
SRA | 1 | Rachel Danielle Saxe | Feb 12, 2025 | ||||
GSM8788639 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, Tamoxifen 6h, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788638 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, Tamoxifen 6h, rep1
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788637 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, Tamoxifen 1h, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788636 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, Tamoxifen 1h, rep1
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788635 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, Tamoxifen d0-d4, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788634 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, Tamoxifen d0-d4, rep1
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788633 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, Tamoxifen d0-d2, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788632 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, Tamoxifen d0-d2, rep1
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788631 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, untreated, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788630 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 4, untreated, rep1
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788629 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 2, Tamoxifen d0-d2, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788628 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 2, Tamoxifen d0-d2, rep1
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788627 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 2, untreated, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788626 |
ATAC-seq Otx2-/- OTX2-ERT2 PGCLC aggregates, plus cytokines, day 2, untreated, rep1
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788625 |
ATAC-seq Otx2-/- OTX2-ERT2 EpiLCs, Tamoxifen 6h, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 | |||
GSM8788624 |
ATAC-seq Otx2-/- OTX2-ERT2 EpiLCs, Tamoxifen 1h, rep2
|
SRA | 1 |
|
Elisa Barbieri | Feb 17, 2025 |